News

Zetia is the first in a class of cholesterol-lowering agents that inhibits the intestinal absorption of cholesterol through a unique mechanism of action. With this new indication, Zetia

Currently, Velcade has been approved by the FDA for the treatment of multiple myeloma patients who have received at least one prior therapy. To date, over 33,000 multiple

Gleevec, currently used to treat a number of cancers including chronic myelogenous leukemia, destroyed tumors in the study by cutting of the blood supply to them. The results

The new dosing strengths, 5/40mg and 10/40mg, combine the calcium channel blocker (CCB) amlodipine with the highest available dose of the ACE inhibitor benazepril. According to Novartis, Lotrel

The combined company, which will operate under the “PharmAthene” name, is expected to be a leader in biodefense featuring a substantial portfolio of procurement-stage biodefense products targeting anthrax,

The FDA informed the company in February 2006 that it would not approve the drug, but the recent meeting has given the company hope that a path to

Gardasil is designed to prevent the majority of human papillomavirus (HPV)-related clinical diseases, those caused by HPV 6, 11, 16 and 18. HPV types 16 and 18 account

Orphan drug designation entitles Hana Biosciences to seven years of market exclusivity for ropidoxuridine in the treatment of malignant glioma. Additional incentives include tax credits related to clinical

The phase II clinical trials will be conducted in cancer centers in the US and Europe. These studies will include patients with ovarian cancer who are experiencing their